Healthcare >> Sector Roundtables >> December 4, 2000
MARIOLA B. HAGGAR is President, General Partner and Portfolio
Manager at Haggar Concord Partners, LP. Ms. Haggar was previously
associated with Deutsche Banc Alex. Brown and Salomon Brothers as
a Pharmaceutical Analyst. Prior to that she was employed at
Kemper Securities Group, Inc., L.F. Rothschild and Unterberg,
Towbin and began her career at Kidder Peabody & Co. in 1982. Ms.
Haggar received a BA in Biochemistry from Cornell University and
an MPH from Columbia University. Profile
FREDERICK A. WISE, CFA, is a Managing Director at Bear, Stearns &
Co., covering the medical supplies and devices industry. Mr. Wise
is a six-year member of the Institutional Investor All America
Research Team. In 1999 he was ranked number two and in 2000 he
was ranked number three. He was named to the 2000 Wall Street
Journal All-Star Analysts Survey for earnings forecasting. He was
also ranked number four by The Reuters Survey 2000. Mr. Wise has
a unique valuation approach, and has accurately anticipated the
underperformance of stocks, as well as the performance of the
industry in recent years. Prior to joining Bear Stearns, he was
an Analyst at Kidder Peabody & Co. and Forbes, Inc. Mr. Wise
received an MA and a BA from the Manhattan School of Music. Profile
BRUCE JACOBS is a Vice President at Deutsche Banc Alex. Brown covering
the medical device and hospital supply group. Mr. Jacobs is a CFA. He
received a BSE in Finance and Management from the Wharton School and
graduated Magna Cum Laude and received an MBA from Harvard Business
School. In his leisure he enjoys sports and traveling. Profile
ANNE P. MALONE, CFA, is a Vice President at Salomon Smith Barney,
covering Medical Technology Industry. She was previously associated with
Bear Stearns & Company. Ms. Malone is a Chartered Financial Analyst and
a member of the New York Society of Security Analysts. She received a BA
in Finance, with a minor in Economics from St. Leo College. Profile
technology and devices stocks over the past 12 months. Anne, to what do
you attribute the upturn in the stocks?
Ms. Malone: At
